High dose mitoxantrone and melphalan followed by autologous stem cell transplantation for lymphoid malignancies

被引：1
|
作者：
Chan, GW [1 ]
Sprague, KA [1 ]
Klein, AK [1 ]
Klingemann, HG [1 ]
机构：
[1] Tufts New England Med Ctr, Boston, MA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
276
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [21] High-dose thiotepa, melphalan and carboplatin followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - a retrospective evaluation
    Demirer, T
    Soydan, E
    Fen, T
    Ilhan, O
    Ayli, M
    Arat, M
    Ozcan, M
    Gunel, N
    Arslan, O
    Genc, Y
    Uysal, A
    Haznedar, R
    Buyukberber, S
    Gurman, G
    Ustaer, N
    Hazar, B
    Ozet, G
    Akan, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S250 - S250
  • [22] Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma
    Kim, Ji-Won
    Lee, Hyun Jung
    Yi, Hyeon Gyu
    Kim, Byung-Su
    Bang, Soo-Mee
    Kim, Jin Seok
    Kim, Inho
    Yoon, Sung-Soo
    Lee, Jong Seok
    Kim, Chul Soo
    Park, Seonyang
    Kim, Byoung Kook
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (05) : 479 - 483
  • [23] The reason why high-dose melphalan followed by autologous stem-cell transplantation produces good response in multiple myeloma
    Kuroda, Y
    Sakai, A
    Okikawa, Y
    Munemasa, S
    Katayama, Y
    Takimoto, Y
    Okita, H
    Kimura, A
    BLOOD, 2004, 104 (11) : 385B - 385B
  • [24] Treatment of AL amyloidosis with tandem cycles of high dose melphalan and autologous stem cell transplantation
    Sanchorawala, V
    Wright, DG
    Quillen, K
    Kunz, R
    Finn, KT
    Malek, K
    Falk, RH
    Berk, JL
    Dember, LM
    Skinner, M
    Seldin, DC
    BLOOD, 2003, 102 (11) : 117A - 117A
  • [25] High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    ACTA HAEMATOLOGICA, 2020, 143 (04) : 381 - 387
  • [26] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, M.
    Buyukasik, Y.
    Demiroglu, H.
    Malkan, U.
    Ciftciler, R.
    Aladag, E.
    Aksu, S.
    Haznedaroglu, I.
    Sayinalp, N.
    Ozcebe, O.
    Goker, H.
    LEUKEMIA RESEARCH, 2018, 73 : S27 - S27
  • [27] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, Mufide
    Buyukasik, Yahya
    Demiroglu, Haluk
    Malkan, Umit Yavuz
    Ciftciler, Rafiye
    Aladag, Elifcan
    Aksu, Salih
    Haznedaroglu, Ibrahim Celalettin
    Sayinalp, Nilgun
    Ozcebe, Osman Ilhami
    Goker, Hakan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 985 - 992
  • [28] High-dose chemotherapy and autologous stem cell transplantation in treating paediatric malignancies
    Valteau-Couanet, D.
    Dufour, C.
    Hartmann, O.
    ONCOLOGIE, 2007, 9 (12) : 827 - 831
  • [29] High-dose melphalan and autologous stem cell transplantation followed by non-myeloablative conditioning regime and allogeneic stem cell transplantation as consolidation therapy in multiple Myeloma.
    Schneider, P
    Fenk, R
    Bernhardt, A
    Rohr, U
    Till, E
    Wehmeier, A
    Haas, R
    Kobbe, G
    BLOOD, 2001, 98 (11) : 351B - 351B
  • [30] A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
    Demirer, T
    Ilhan, O
    Mandel, NM
    Arat, M
    Günel, N
    Çelebi, H
    Üstün, C
    Akan, H
    Demirer, S
    Aydintug, S
    Uysal, A
    Koc, H
    BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 697 - 703
12345